ThousandEyes
Security and trust center evidence
Summary
ThousandEyes has 2 registry-verified rows, and 1 expired in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 2026-09-17, ThousandEyes is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 2026-03-05 and Schellman Compliance, LLC named as auditor. As of 2026-09-17, ThousandEyes is listed in the CSA STAR registry at STAR Level 1 self-assessment (CAIQ), designated Trusted Cloud Provider, originally issued 2018-10-08. As of 2026-09-17, ThousandEyes' EU-US Data Privacy Framework status is listed as expired, with status text 'Inactive'. No public evidence found for SOC 2 as of 2026-09-17. No public evidence found for HIPAA as of 2026-09-17.
- FedRAMP: listed in registry as FedRAMP Authorized, issued 2026-03-05, auditor Schellman Compliance, LLC (as of 2026-09-17)
- CSA STAR: listed in registry at STAR Level 1 (CAIQ) self-assessment, Trusted Cloud Provider, issued 2018-10-08 (as of 2026-09-17)
- EU-US Data Privacy Framework: listed as expired/Inactive (as of 2026-09-17)
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among devops and observability vendors
2verified rows
Category median 1, across 90 indexed devops and observability vendors. ThousandEyes has more verified rows than 88 percent of them.
application performanceincident detectionnetwork monitoringobservability
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the DevOps and observability category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
